BELLICUM PHARMACEUTICALS INC (BLCM) Stock Analyst Ratings
NASDAQ:BLCM - Nasdaq - US0794814048 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to BLCM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 719.94% above the current price.
BLCM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BLCM.
In the previous month the buy percentage consensus was at a similar level.
BLCM was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-16 | Ladenburg Thalmann | Initiate | Buy |